Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,734 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,371
Recruiting: 3,969
Ph III recruiting: 536
Growth YoY: +9.5%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,407)

clinicaltrialsPublishedShowing 651–700 of 1,619 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07537959	Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases	not yet recruiting	N/A	280	Tongji HospitalOTHER	1	Apr 17, 2026	clinicaltrials
NCT07537972	Denosumab Strategy for Liver Cancer With Bone Metastases	not yet recruiting	Phase 2	50	Tongji HospitalOTHER	1	Apr 17, 2026	clinicaltrials
NCT07361133